Study registration: *
Publication Amirthalingam G, medRxiv, 2021
Dates: 2021-02-01 to 2021-06-20
Funding: Public/non profit (Public Health England)
Conflict of interest: Yes (MER reports that the Immunisation and Countermeasures Division (PHE) has provided vaccine manufacturers with post-marketing surveillance reports on pneumococcal and meningococcal infection, which the companies are required to submit to the UK licensing authority in compliance with their risk management strategy. A cost-recovery charge is made for these reports. EL report that the PHE Vaccine Evaluation Unit does contract research on behalf of GlaxoSmithKline, Sanofi, and Pfizer, which is outside the submitted work.)